Logo image of SCPX

SCORPIUS HOLDINGS INC (SCPX) Stock Fundamental Analysis

USA - NYSE Arca - NYSEARCA:SCPX - US42237K5083 - Common Stock

0.068 USD
-0.06 (-48.48%)
Last: 4/21/2025, 8:04:00 PM
Fundamental Rating

2

Overall SCPX gets a fundamental rating of 2 out of 10. We evaluated SCPX against 530 industry peers in the Biotechnology industry. SCPX may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, SCPX is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year SCPX has reported negative net income.
In the past year SCPX has reported a negative cash flow from operations.
In the past 5 years SCPX always reported negative net income.
In the past 5 years SCPX always reported negative operating cash flow.
SCPX Yearly Net Income VS EBIT VS OCF VS FCFSCPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 -10M -20M -30M -40M

1.2 Ratios

Looking at the Return On Assets, with a value of -72.96%, SCPX is doing worse than 66.49% of the companies in the same industry.
SCPX has a worse Return On Equity (-128.83%) than 60.32% of its industry peers.
Industry RankSector Rank
ROA -72.96%
ROE -128.83%
ROIC N/A
ROA(3y)-53.06%
ROA(5y)-51.43%
ROE(3y)-77.93%
ROE(5y)-80.68%
ROIC(3y)N/A
ROIC(5y)N/A
SCPX Yearly ROA, ROE, ROICSCPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -50 -100 -150

1.3 Margins

SCPX has a Gross Margin of 68.54%. This is amongst the best in the industry. SCPX outperforms 80.60% of its industry peers.
The Profit Margin and Operating Margin are not available for SCPX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 68.54%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SCPX Yearly Profit, Operating, Gross MarginsSCPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 -1K -2K -3K

More info and screens

0

2. Health

2.1 Basic Checks

SCPX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SCPX has been increased compared to 1 year ago.
Compared to 1 year ago, SCPX has a worse debt to assets ratio.
SCPX Yearly Shares OutstandingSCPX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M 25M
SCPX Yearly Total Debt VS Total AssetsSCPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

SCPX has an Altman-Z score of -9.40. This is a bad value and indicates that SCPX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of SCPX (-9.40) is worse than 72.66% of its industry peers.
A Debt/Equity ratio of 0.31 indicates that SCPX is not too dependend on debt financing.
SCPX has a Debt to Equity ratio of 0.31. This is in the lower half of the industry: SCPX underperforms 71.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -9.4
ROIC/WACCN/A
WACC4.43%
SCPX Yearly LT Debt VS Equity VS FCFSCPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

SCPX has a Current Ratio of 0.38. This is a bad value and indicates that SCPX is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.38, SCPX is not doing good in the industry: 94.36% of the companies in the same industry are doing better.
A Quick Ratio of 0.26 indicates that SCPX may have some problems paying its short term obligations.
SCPX has a worse Quick ratio (0.26) than 95.24% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.26
SCPX Yearly Current Assets VS Current LiabilitesSCPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 20.42% over the past year.
Looking at the last year, SCPX shows a very strong growth in Revenue. The Revenue has grown by 947.53%.
SCPX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.85% yearly.
EPS 1Y (TTM)20.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
Revenue 1Y (TTM)947.53%
Revenue growth 3Y33.35%
Revenue growth 5Y3.85%
Sales Q2Q%356.36%

3.2 Future

Based on estimates for the next years, SCPX will show a very strong growth in Earnings Per Share. The EPS will grow by 41.10% on average per year.
SCPX is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 80.70% yearly.
EPS Next Y97.7%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year63.27%
Revenue Next 2Y80.7%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
SCPX Yearly Revenue VS EstimatesSCPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M
SCPX Yearly EPS VS EstimatesSCPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10K -20K -30K

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

SCPX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for SCPX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SCPX Price Earnings VS Forward Price EarningsSCPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SCPX Per share dataSCPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 -4

4.3 Compensation for Growth

SCPX's earnings are expected to grow with 41.10% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.1%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SCPX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

SCORPIUS HOLDINGS INC

NYSEARCA:SCPX (4/21/2025, 8:04:00 PM)

0.068

-0.06 (-48.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)04-30 2025-04-30/amc
Earnings (Next)05-26 2025-05-26
Inst Owners0.19%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner Change0%
Market Cap331.16K
Revenue(TTM)9.74M
Net Income(TTM)-36.85M
Analysts82.86
Price Target5.1 (7400%)
Short Float %0.13%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA N/A
EPS(TTM)-1.38
EYN/A
EPS(NY)-2.97
Fwd EYN/A
FCF(TTM)-4.74
FCFYN/A
OCF(TTM)-4.61
OCFYN/A
SpS2
BVpS5.87
TBVpS5.87
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -72.96%
ROE -128.83%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 68.54%
FCFM N/A
ROA(3y)-53.06%
ROA(5y)-51.43%
ROE(3y)-77.93%
ROE(5y)-80.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.24%
Cap/Sales 6.83%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.26
Altman-Z -9.4
F-Score3
WACC4.43%
ROIC/WACCN/A
Cap/Depr(3y)326.96%
Cap/Depr(5y)240.26%
Cap/Sales(3y)144.6%
Cap/Sales(5y)90.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)20.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%68%
EPS Next Y97.7%
EPS Next 2Y41.1%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)947.53%
Revenue growth 3Y33.35%
Revenue growth 5Y3.85%
Sales Q2Q%356.36%
Revenue Next Year63.27%
Revenue Next 2Y80.7%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y22.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y48.43%
OCF growth 3YN/A
OCF growth 5YN/A

SCORPIUS HOLDINGS INC / SCPX FAQ

What is the fundamental rating for SCPX stock?

ChartMill assigns a fundamental rating of 2 / 10 to SCPX.


Can you provide the valuation status for SCORPIUS HOLDINGS INC?

ChartMill assigns a valuation rating of 1 / 10 to SCORPIUS HOLDINGS INC (SCPX). This can be considered as Overvalued.


What is the profitability of SCPX stock?

SCORPIUS HOLDINGS INC (SCPX) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for SCPX stock?

The Earnings per Share (EPS) of SCORPIUS HOLDINGS INC (SCPX) is expected to grow by 97.7% in the next year.